Heartland IPOs

Midwest cancer vaccine companies in play: NewLink prices IPO, Tvax files

Heartland IPOs

One Midwestern cancer vaccine play priced an IPO last week, while another filed.

On Friday, Iowa's NewLink Genetics Corp. (NASDAQ:NLNK) raised $43.4 million in an IPO that priced

Read the full 284 word article

How to gain access

Continue reading with a
two-week free trial.